Analysis of Geographic Areas
Pfizer Inc. operates in 4 regions: United States; Developed Europe; Developed Rest of World; and Emerging Markets.
Area Asset Turnover
Pfizer Inc., asset turnover by geographic area
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| United States | 2.54 | 4.63 | 3.55 | 2.78 | 3.14 |
| Developed Europe | 1.87 | 4.08 | 3.60 | 1.63 | 2.02 |
| Developed Rest of World | 26.77 | 53.85 | 36.04 | 9.77 | 14.27 |
| Emerging Markets | 6.83 | 14.22 | 19.60 | 9.41 | 7.94 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio improved from 2021 to 2022 but then deteriorated significantly from 2022 to 2023. |
| Developed Europe | Developed Europe area asset turnover ratio improved from 2021 to 2022 but then deteriorated significantly from 2022 to 2023. | |
| Developed Rest of World | Developed Rest of World area asset turnover ratio improved from 2021 to 2022 but then deteriorated significantly from 2022 to 2023. | |
| Emerging Markets | Emerging Markets area asset turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Area Asset Turnover: United States
Pfizer Inc.; United States; area asset turnover calculation
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Revenues | 27,088) | 42,473) | 29,746) | 21,712) | 23,852) |
| Long-lived assets | 10,673) | 9,179) | 8,385) | 7,821) | 7,606) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 2.54 | 4.63 | 3.55 | 2.78 | 3.14 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Area asset turnover = Revenues ÷ Long-lived assets
= 27,088 ÷ 10,673 = 2.54
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio improved from 2021 to 2022 but then deteriorated significantly from 2022 to 2023. |
Area Asset Turnover: Developed Europe
Pfizer Inc.; Developed Europe; area asset turnover calculation
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Revenues | 11,650) | 21,982) | 18,336) | 7,788) | 8,701) |
| Long-lived assets | 6,221) | 5,389) | 5,094) | 4,775) | 4,304) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 1.87 | 4.08 | 3.60 | 1.63 | 2.02 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Area asset turnover = Revenues ÷ Long-lived assets
= 11,650 ÷ 6,221 = 1.87
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Developed Europe | Developed Europe area asset turnover ratio improved from 2021 to 2022 but then deteriorated significantly from 2022 to 2023. |
Area Asset Turnover: Developed Rest of World
Pfizer Inc.; Developed Rest of World; area asset turnover calculation
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Revenues | 7,762) | 15,778) | 12,506) | 4,036) | 6,465) |
| Long-lived assets | 290) | 293) | 347) | 413) | 453) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 26.77 | 53.85 | 36.04 | 9.77 | 14.27 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Area asset turnover = Revenues ÷ Long-lived assets
= 7,762 ÷ 290 = 26.77
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Developed Rest of World | Developed Rest of World area asset turnover ratio improved from 2021 to 2022 but then deteriorated significantly from 2022 to 2023. |
Area Asset Turnover: Emerging Markets
Pfizer Inc.; Emerging Markets; area asset turnover calculation
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Revenues | 11,996) | 20,097) | 20,701) | 8,372) | 12,733) |
| Long-lived assets | 1,756) | 1,413) | 1,056) | 890) | 1,603) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 6.83 | 14.22 | 19.60 | 9.41 | 7.94 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Area asset turnover = Revenues ÷ Long-lived assets
= 11,996 ÷ 1,756 = 6.83
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Emerging Markets | Emerging Markets area asset turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Long-lived assets
Pfizer Inc., long-lived assets by geographic area
US$ in millions
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| United States | 10,673) | 9,179) | 8,385) | 7,821) | 7,606) |
| Developed Europe | 6,221) | 5,389) | 5,094) | 4,775) | 4,304) |
| Developed Rest of World | 290) | 293) | 347) | 413) | 453) |
| Emerging Markets | 1,756) | 1,413) | 1,056) | 890) | 1,603) |
| Total | 18,940) | 16,274) | 14,882) | 13,899) | 13,966) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Revenues
Pfizer Inc., revenues by geographic area
US$ in millions
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| United States | 27,088) | 42,473) | 29,746) | 21,712) | 23,852) |
| Developed Europe | 11,650) | 21,982) | 18,336) | 7,788) | 8,701) |
| Developed Rest of World | 7,762) | 15,778) | 12,506) | 4,036) | 6,465) |
| Emerging Markets | 11,996) | 20,097) | 20,701) | 8,372) | 12,733) |
| Total | 58,496) | 100,330) | 81,289) | 41,908) | 51,751) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).